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A B S T R A C T
Background: Eﬀects of beta-amyloid accumulation on neuronal function precede the clinical manifestation of
Alzheimer's disease (AD) by years and aﬀect distinct cognitive brain networks. As previous studies suggest a link
between beta-amyloid and dysregulation of excitatory and inhibitory neurotransmitters, we aimed to investigate
the impact of GABA and glutamate on beta-amyloid related functional connectivity.
Methods: 29 cognitively unimpaired old-aged adults (age= 70.03 ± 5.77 years) were administered 11C-
Pittsburgh Compound B (PiB) positron-emission tomography (PET), and MRI at 7 Tesla (7T) including blood
oxygen level dependent (BOLD) functional MRI (fMRI) at rest for measuring static and dynamic functional
connectivity. An advanced 7T MR spectroscopic imaging (MRSI) sequence based on the free induction decay
acquisition localized by outer volume suppression’ (FIDLOVS) technology was used for gray matter speciﬁc
measures of GABA and glutamate in the posterior cingulate and precuneus (PCP) region.
Results: GABA and glutamate MR-spectra indicated signiﬁcantly higher levels in gray matter than in white
matter. A global eﬀect of beta-amyloid on functional connectivity in the frontal, occipital and inferior temporal
lobes was observable. Interactive eﬀects of beta-amyloid with gray matter GABA displayed positive PCP con-
nectivity to the frontomedial regions, and the interaction of beta-amyloid with gray matter glutamate indicated
positive PCP connectivity to frontal and cerebellar regions. Furthermore, decreased whole-brain but increased
fronto-occipital and temporo-parietal dynamic connectivity was found, when GABA interacted with regional
beta-amyloid deposits in the amygdala, frontal lobe, hippocampus, insula and striatum.
Conclusions: GABA, and less so glutamate, may moderate beta-amyloid related functional connectivity.
Additional research is needed to better characterize their interaction and potential impact on AD.
1. Introduction
Coherent brain network activity is an indicator of healthy brain
functioning and depends on a balanced interplay between inhibitory
and excitatory neuronal activity (Ferreira and Busatto, 2013; Fox and
Raichle, 2007; Seeley, 2017; van den Heuvel et al., 2009). Neurode-
generative diseases are characterized by an aggregation of various
pathological proteins (Robinson et al., 2018) that is associated with
compromised coordination of neuronal brain activity (Brettschneider
et al., 2015; Jagust and Mormino, 2011). Alzheimer's disease (AD) is
the most frequent cause for neurodegenerative dementia at high age
and is characterized by a decade long preclinical phase during which
beta-amyloid pathology manifests, while cognitive performance re-
mains normal for a long time (Dubois et al., 2016; Sperling et al., 2011).
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Moreover, the presence of beta-amyloid in AD risk-populations is as-
sociated with distinct changes in brain network activity, as indicated by
altered patterns of synchronous neural activity of functionally con-
nected brain regions (Franzmeier et al., 2017; Mormino et al., 2011;
Sepulcre et al., 2017; Sorg et al., 2007; Steininger et al., 2014; Teipel
et al., 2016b). Interestingly, beta-amyloid related connectivity changes
particularly aﬀect intrinsic cognitive networks such as the default mode
network (DMN) (Buckner et al., 2009; Hedden et al., 2009; Sheline
et al., 2010). A characteristic feature of intrinsic networks such as the
DMN is that they are constituted by distinct sets of functionally con-
nected ‘hubs’ that synchronously activate at rest (Buckner et al., 2008;
Greicius et al., 2003; Raichle et al., 2001). Activity of intrinsic brain
networks may be inferred on by measuring ‘static’ connectivity of
neuronal tissue to a major network hub using blood oxygen level de-
pendent (BOLD) functional magnetic resonance imaging (fMRI) at rest
(Friston et al., 1993). More recently, also approaches for measuring
‘dynamic’ connectivity have been established that allow for the varia-
bility of functional connectivity within networks over time (Chang and
Glover, 2010; Handwerker et al., 2012; Hutchison et al., 2013; Preti
et al., 2017).
The posterior cingulate and precuneus (PCP) region is a major ‘hub’
in various intrinsic brain networks, and pathological change pertaining
to the PCP is a robust ﬁnding in preclinical AD (Esposito et al., 2013;
Lustig et al., 2003; Sheline et al., 2010; Teipel et al., 2016a). Moreover,
as the PCP plays a central role for episodic memory processing, this is
consistent with episodic memory typically being ﬁrst aﬀected when
cognitive impairment manifests in the course of AD (Albert et al., 2011;
Cieri and Esposito, 2018).
GABA and glutamate represent major excitatory and inhibitory
neurotransmitters in the human central nervous system. A concatena-
tion of preclinical studies suggest that beta-amyloid aggregation is
linked to local dysfunction of neuronal inhibition and excitation (Bero
et al., 2011; Busche et al., 2008; Palop et al., 2007; Ulrich, 2015).
However, to our knowledge, the interaction between GABA, glutamate
and beta-amyloid has not been investigated in human in vivo study
populations yet.
Allowing for these earlier ﬁndings that suggest an intimate re-
lationship between beta-amyloid and both regulation of neuronal in-
hibition and excitation, we hypothesized that the impact of patholo-
gical beta-amyloid on intrinsic brain network activity is moderated by
GABA and glutamate. Thus, aims of the current study were: (1) to de-
termine presence and activity of intrinsic beta-amyloid associated brain
networks in cognitively unimpaired old-aged adults at rest; (2) to es-
tablish whether Glutamate and GABA moderate eﬀects of beta-amyloid
on network activity.
To this eﬀect, GABA and glutamate were speciﬁcally assessed in
gray and also white matter of the PCP using magnetic resonance
spectroscopic imaging (MRSI) based on the ‘free induction decay ac-
quisition localized by outer volume suppression’ (FIDLOVS) metho-
dology (Henning et al., 2009) at ultra-high ﬁeld strength of 7 Tesla (7 T)
for increased spatial resolution of spectral information and increased
signal-to-noise ratio (SNR). Beta-amyloid plaque density was assessed
by 11C-Pittsburgh-Compound B (PiB) positron emission tomography
(PET) (Klunk et al., 2004). ‘Static’ functional connectivity was measured
using the PCP as a seed for BOLD synchronicity at rest (Whitﬁeld-
Gabrieli and Nieto-Castanon, 2012). In addition, whole-brain ‘dynamic’
connectivity was assessed as a measure of the temporal dynamics of
BOLD synchronicity patterns (Allen et al., 2014) by applying a sliding
time window approach (Leonardi et al., 2013; Richiardi et al., 2012).
2. Materials and methods
2.1. Study population
The study sample included a total of 29 (17 males, 12 females)
cognitively unimpaired old-aged adults (mean age:
69.75 ± 5.57 years), who where recruited from an ongoing cohort
study of ours (Gietl et al., 2015; Schreiner et al., 2014; Steininger et al.,
2014). Due to missing MRSI data, not all 29 participants were included
in the subsequent combined connectivity analyses (see Table 1). To
ensure normal cognitive performance, potential study participants were
cognitively evaluated by applying a battery of neuropsychological tests
as indicated earlier (Quevenco et al., 2017b). These included the Mini-
mental State Examination (MMSE) (Folstein et al., 1975) as a screening
test for present cognitive impairment. For detection of isolated neu-
ropsychological deﬁcits in potential study participants, additionally the
Revised Boston Naming Test (BNT) (Nicholas et al., 1988), Digit Spans
Backward (Gregoire and Van der Linden, 1997), Trail Making Test
(TMT) B/A (Tombaugh, 2004); Verbal Learning And Memory Test
(VLMT): delayed recall (Lange et al., 2002) were performed. Exclusion
criteria were: any present medication that may aﬀect cognition, general
magnetic resonance imaging (MRI) exclusion criteria, contraindications
against venipuncture, clinically relevant changes in red blood cell
count, any acute severe medical, neurological or psychiatric condition,
present or past drug abuse, allergy to the PET tracer 11C-PiB, sig-
niﬁcant earlier exposure to radiation. Moreover, any participant who
showed MRI evidence of infarction, focal or signiﬁcant hemorrhagic
lesions, was excluded from this study. The Apolipoprotein E ε4 allele
was assessed to detect possible overrepresentation of genetic risk for AD
and brain amyloidosis in the investigated sample (Corder et al., 1993;
Kantarci et al., 2012). All study procedures were carried out in ac-
cordance with regulatory requirements (Kantonale Ethikkommission
Zürich, www.kek.zh.ch) and the Declaration of Helsinki. Written in-
formed consent was obtained from all candidates prior to participation
in thi study.
2.2. Acquisition of MRI data
All participants underwent a single scanning session in a Philips
Achieva 7-Tesla (7 T) whole-body scanner (Philips Healthcare, Best,
The Netherlands) equipped with a Nova Medical quadrature transmit
head coil and a 32-channel receive coil array. High-resolution T1-
weighted 3D-MPRAGE structural images (repetition time (TR)/echo
time (TE)= 8.22ms/3.74ms, voxel size= 0.86×0.86, scan dura-
tion= 653.71 s, slice thickness= 0.9 mm, ﬂip angle= 7°,
FOV=220×157.5× 198.36) were obtained for referencing, auto-
mated multi-channel image segmentation, and localization of the vo-
lumes of interest (VOIs) for magnetic resonance spectroscopic imaging
(MRSI), as done in earlier studies of ours (Schreiner et al., 2018;
Schreiner et al., 2016). In brief, we acquired a reﬁned high-resolution
direct free-induction-decay (FID) sequence (acquisition delay=2.5ms,
TR=644ms, in-plane resolution=3.5×3.5mm2, slice thick-
ness= 12mm, scan duration=1762s) based on "FID acquisition, lo-
calized by outer volume suppression" (FIDLOVS) (Henning et al., 2009),
with water suppression similar to variable power RF pulses with opti-
mized relaxation delays (VAPOR) (Tkac et al., 1999), but without outer
Table 1
Demographics of the sample population. The last column contains p-values of
two-sample t-tests to ensure there are no signiﬁcant demographic diﬀerences
between the GABA and Glutamate sample.
All GABA Glutamate p-values
N total 29 24 28 N/A
Age 70.03 ± 5.77 69.54 ± 5.76 69.43 ± 5.37 0.91
Males 17 14 17 0.86
ApoE-e4 8 7 7 0.74
MMSE 29.41 ± 0.81 29.46 ± 0.85 29.48 ± 0.82 0.88
BMI 25.62 ± 3.77 24.95 ± 2.99 25.44 ± 3.78 0.57
Education (in years) 15.83 ± 2.48 16.00 ± 2.54 15.79 ± 2.38 0.88
Cortical PiB
Ratio
PiB +
1.25 ± 0.34
3
1.22 ± 0.29
2
1.21 ± 0.27
2
0.93
N/A
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volume or fat suppression (Bogner et al., 2012). Dynamic B0 shimming
was conducted to reduce magnetic ﬁeld inhomogeneities particularly
due to the absence of outer volume or fat suppression (Fillmer et al.,
2015). To obtain the exact anatomical reference of these images, a T1-
weighted structural turbo spin echo (TSE) image (TR/TE=5.7ms/
2.9 ms, resolution=0.9×0.9×1.5mm) was acquired using the same
FOV dimensions as the MRSI slab. Resting-state fMRI data for each
subject was acquired using an echo planar imaging (EPI) sequence
(TR=2500ms, slice thickness= 3mm, ﬂip angle= 45°, voxel
size= 1.719×1.719mm, scan duration=537.5 s, number of
slices= 50, FOV=220x150x220mm).
2.3. Deﬁning the posterior cingulate/Precuneus (PCP) slab for metabolite
measurement
To assess MRSI metabolites in the Posterior Cingulate/Precuneus
(PCP), the Hammers atlas, a 3-dimensional maximum probability atlas
of the human brain containing 83 anatomical labels (Gousias et al.,
2008; Hammers et al., 2003), was modiﬁed in-house to generate a
binary mask of the PCP. This ROI comprised the PCP, corresponding to
the Brodmann areas BA 31 and the medial parts of BA 7. The superior
and inferior anatomical borders were deﬁned by the extent of the MRSI
slab in the z direction, the rostral border by the posterior part of the
Anterior Cingulate cortex, and the posterior border by the Postero-oc-
cipital ﬁssure. Custom ROIs were acquired using a pipeline applied to
the anatomical ROIs of the PCP per subject (Schreiner et al., 2016).
2.4. Acquisition of PET data
Cortical beta-amyloid deposits were measured using Positron
Emission Tomography (PET) with the tracer 11-C Pittsburgh Compound
B (PiB) (Klunk et al., 2004). Participants were intravenously adminis-
tered a dose of approximately 350MBq of the tracer and amyloid de-
position was estimated based on late frame signals representing
50–70min post-injection. Measures of cerebral beta-amyloid load per
subject was derived from the ratio of standardized uptake values (SUV)
of cortical PiB-VOIs, referenced to cerebellar gray matter SUV after co-
registration using the PMOD brain tool (PNEURO) software, Version 3.4
(PMOD Technologies Ltd., Zurich, Switzerland) as described in our
previous studies (Schreiner et al., 2016; Steininger et al., 2014). Stan-
dardized PiB-SUV were used to calculate cortical to cerebellar PiB re-
tention ratio units (“cortical-PiB”) (Jack et al., 2009), and to determine
“amyloid-positive” status using an earlier deﬁned threshold of ours
(Gietl et al., 2015).
2.5. Processing of magnetic resonance spectroscopic imaging (MRSI) data
The post-processing pipeline of MRSI data conducted, is identical to
the pipeline used in an earlier publication (Schreiner et al., 2016).
Tissue-speciﬁc anatomical sub-regions of PCP were deﬁned on the MRSI
slab that covered the PCP region. GABA and glutamate, referenced to
Creatine, were estimated with LC model (Provencher, 2001) from
averaged MRSI spectra from PCP gray matter and white matter sepa-
rately.
Suﬃcient MRSI quality was determined by visual inspection of all
spectra (Fig. 1), as conducted in previous studies (Schreiner et al., 2018;
Schreiner et al., 2016) and applying recommended cut-oﬀs for SNR (Oz
G, Alger JR, Barker PB, et al. Clinical proton MR spectroscopy in central
nervous system disorders. Radiology. 2014 Mar;270(3):658-79). Fur-
ther, we only considered spectra with relative Cramér-Rao Lower
Bounds (CRLB)< 30%, despite the common practice of using relative
CRLB<20%. We chose this more liberal threshold, as a strict usage of
relative CRLB may introduce bias by underestimating changes in me-
tabolites with low levels (Kreis, 2016), e.g. GABA.
2.6. Processing of fMRI data and assessment of dynamic functional
connectivity
Structural and functional images were preprocessed using a stan-
dardized in-house developed pipeline (Richiardi et al., 2012). This pi-
peline was implemented with MATLAB scripts (MATLAB 2015b, Ver-
sion 8.6, MathWorks Inc., Natick, MA, USA), including functions from
SPM8 and SPM12 (www.ﬁl.ion.ucl.uk/spm) and DPARSFA toolboxes
(Chao-Gan and Yu-Feng, 2010). Preprocessing parameters used in this
study are identical to those used in an earlier dynamic functional
connectivity study (Quevenco et al., 2017b). The images were spatially
realigned and smoothed and nuisance variables were regressed out
from the regional time series. The functional volumes were then re-
gionally parcellated using the automated anatomical labelling (AAL)
atlas. Regional mean time series were extracted by averaging the pre-
processed BOLD signal over all voxels in each region.
A sliding time window approach was used (window size: 24TRs
(=60s), step: 1TR (=2.5 s)) to calculate the time-varying correlations
between BOLD ﬂuctuations in distinct brain regions. PCA was then used
to extract meaningful connectivity patterns (‘eigenconnectivities’) that
best capture dynamic functional connectivity (Quevenco et al., 2017b).
These patterns are characterized by two main conﬁgurations: positive/
red connections denote an increase in connectivity between a set of
nodes, whereas negative/blue illustrate decreased connectivity between
a given set of nodes.
The weighted time contributions of each eigenconnectivity (net-
work) were calculated by projecting dynamic functional connectivity
on a select number of eigenconnectivities. An eigenconnectivity
number of 10 was suﬃcient to explain 37% of data variance when
taking the diagonal of the decomposed PCA matrix, as indicated in
previous studies of ours (Leonardi et al., 2013; Quevenco et al., 2017a).
The measure assessed according to our predictor variables was the
percentage of positive weights of each eigenconnectivity, which illustrates
the propensity of an eigenconnectivity's preference towards increased
connectivity between the red nodes and less connectivity between the
blue nodes. Network signs (positive or negative) are thus used to il-
lustrate alternations between: (1) increased connectivity (positive/red
connections); and (2) decreased connectivity (negative/blue connec-
tions) between a set of nodes. Percentage of positive weights represents
the amount of time a network contributes with a positive sign. A po-
sitive sign weight indicates a preference for a network to contribute to
the dynamic functional connectivity in the ﬁrst conﬁguration (in-
creased connectivity), whilst a negative sign weight indicates a pre-
ference for an eigenconnectivity to contribute in the second conﬁg-
uration (decreased connectivity).
Multimodal neuroimaging approach of combined 7 T FIDLOVS MRI
(gray matter GABA and glutamate), 11C PiB-PET (beta-amyloid
burden) and 7 T BOLD fMRI at rest (static and dynamic functional
connectivity).
2.7. Statistical tests
All statistical tests were carried out using MATLAB (2015b, Version
8.6), the Statistics and Machine Learning Toolbox (Version 10.0) and
the CONN toolbox (Whitﬁeld-Gabrieli and Nieto-Castanon, 2012).
Static functional connectivity changes in the context of cortical beta-
amyloid and GABA and Glutamate levels in the PCP were assessed using
the CONN toolbox with the MRSI PCP slab as a seed. Thus, any con-
nectivity changes observed would regionally overlap with regions,
where GABA and glutamate measures are obtained. Altered con-
nectivity between identiﬁed regional clusters and the PCP were com-
pared by post-hoc tests using CONN. R2 values were obtained to in-
vestigate the degree of correlation between BOLD ﬂuctuations of these
clusters and the PCP.
Since the obtained PiB-load and metabolite measures are continuous
variables, correlations between predictors and time contribution and
F.C. Quevenco, et al. NeuroImage: Clinical 22 (2019) 101776
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percentage positive weights of the dynamic functional connectivity
were explored. A Canonical Correlation Analysis (CCA) was conducted
to investigate any interaction eﬀects of beta-amyloid with GABA and
glutamate on dynamic functional connectivity measures. Statistical
tests were all corrected for multiple comparisons using False Discovery
Rate (FDR) correction according to the Benjamini-Hochberg procedure
(Benjamini and Hochberg, 1995). This was done by obtaining the
Benjamini-Hochberg critical values for each p-value based on the for-
mula (i/m)Q, where i denotes the individual p-value's rank, m is the
number of tests and Q represents the false discovery rate (0.05). The
original values were then compared to the critical B—H values and the
largest p value that has p < (i/m)Q is signiﬁcant and all the p-values
smaller than it are also considered signiﬁcant. Fig. 1 illustrates the
image processing and workﬂow of all related statistical analyses.
3. Results
3.1. Sample population
Due to missing data or insuﬃcient MRSI quality, 5 participants were
excluded from the GABA analysis and 1 participant from the Glutamate
analysis (see Table 1). In the remaining spectra, SNR was 14.2+4.8 in
PCP GM and 13.0 ± 4.7 in PCP WM, respectively. Relative CRLB for
GABA and Glutamate was 10.4 ± 4.0% and 4.3 ± 2.6% in GM, and
16.0 ± 7.0% and 5.8 ± 3.2% in WM, respectively. Neuropsycholo-
gical testing indicated normal cognitive performance, as reﬂected by
high group scores in the MMSE (29.41 ± 0.81). The study population
included 8 APOE4 carriers, and 3 amyloid-positive participants (Fig. 2).
A: Axial representation of the Posterior Cingulate/Precuneus (PCP)
gray matter (red) and white matter (blue) regions used for the MRSI
analysis. Exemplary spectra analyzed using the LC Model to estimate
average metabolite-levels between the gray (B) and white (C) matter.
The colored lines denote the spectral ﬁt and the black lines denote the
residuals. Arrows mark the peaks for Glutamate (dashed) and GABA
(solid). D: GABA and glutamate levels (each referenced to creatine)
where higher in PCP gray matter (GM) compared to white matter (WM)
(GABA: t(45)= 2.26, p= 0.029; Glutamate: t(50)= 4.24, p < 0.001).
The asterisk indicates signiﬁcance at p < 0.05.
3.2. GABA and glutamate in PCP gray and white matter
By applying MRSI for assessing tissue-type speciﬁc metabolite
measures, signiﬁcantly higher levels of both GABA and Glutamate re-
sulted for gray matter compared to white matter (GABA, gray matter:
mean ± SD: 0.42 ± 0.27; GABA, white matter: 0.3 ± 0.17; t
(45)= 2.26, p= 0.03; Glutamate, gray matter: mean ± SD:
1.32 ± 0.5; Glutamate, white matter: 0.84 ± 0.26; t(50)= 4.24,
p= 0.0001). Subsequent analyses used only gray matter measures of
GABA and glutamate, as brain activity and beta-amyloid were ex-
clusively measured in gray matter and previous work indicated that
MRSI metabolite changes in PCP gray matter are more relevant com-
pared to PCP white matter in a context of aging, cognition, and beta-
amyloid (Schreiner et al., 2018).
Fig. 1. Image processing and analysis workﬂow of PET, MRSI and fMRI data.
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3.3. Beta-amyloid, GABA and glutamate alter static PCP connectivity
Static PCP functional connectivity according to global beta-amyloid
load and GABA and glutamate levels in PCP gray matter were assessed
using the CONN toolbox. Cortical beta-amyloid load was inferred from
PiB measures, thus the term beta-amyloid will be used forthwith instead
of PiB for clarity.
Relationships between cortical beta-amyloid and PCP connectivity
was observable for 10 clusters (6 clusters with negative connectivity).
Positively connected clusters primarily included the Lingual Gyrus, the
left Temporal Fusiform Cortex (posterior division), left Lateral Occipital
Cortex, the left Inferior Temporal Gyrus, the left posterior Middle
Temporal Gyrus, the anterior Parahippocampal Gyrus, the
Hippocampus, the Putamen, Thalamus, the Amygdala, the left
Temporal Pole, and the right Occipital Fusiform Gyrus. Regions with
negative PCP connectivity included the Frontomedial Cortex, the
Subcallosal cortex, the Frontal Orbital Cortex, the right posterior
Inferior Temporal Gyrus, the right posterior Middle Temporal Gyrus,
and the left posterior Parahippocampal Gyrus (Fig. 3).
Rendered 3D brains and coronal brain slices showing regions with
increased (red) connectivity and decreased (blue) PCP connectivity
associated with global cortical beta-amyloid load. Cluster thresholds for
visualization of these clusters were diﬀerent from the analysis with a
cluster threshold of p < 0.05 (FDR-corrected). (For interpretation of
the references to color in this ﬁgure legend, the reader is referred to the
web version of this article.)
The interaction of GABA and beta-amyloid aﬀected a wider array of
regions (18 clusters), with positively associated clusters covering
frontomedial regions, such as Middle Frontal Gyrus, the left Superior
Frontal Gyrus, the right Frontal Orbital Cortex, the right Frontal Pole,
the Precuneus, the Inferior Frontal Gyrus pars triangularis and the
Paracingulate Gyrus and some cerebellar regions. Clusters with nega-
tive PCP connectivity mainly include occipital regions, such as the
Occipital Fusiform Gyrus and the left Occipital Pole (Fig. 4A).
The glutamate and beta-amyloid interaction displayed a diﬀerent
array of altered PCP functional connectivity networks (9 clusters).
Positive PCP connectivity were in clusters covering regions of the
Cerebellum, the Middle Frontal Gyrus, the right Superior Frontal Gyrus,
and the Inferior Frontal Gyrus pars opercularis and similar to GABA,
negatively connected clusters covered occipital areas, including the left
and right Occipital Fusiform Gyrus, the left and right Lingual Gyrus, the
Lateral Occipital Cortex, and the right Temporal Occipital Fusiform
Cortex (Fig. 4B).
Rendered 3D brains and coronal brain slices showing regions with
increased (red) connectivity and decreased (blue) PCP connectivity
associated with (A) GABA interacting with global beta-amyloid, (B)
Glutamate interacting with beta-amyloid. Cluster thresholds for visua-
lization of these clusters were diﬀerent from the analysis with a voxel
height threshold of p < 0.02 (uncorrected) and a cluster threshold of
p < 0.05 (FDR-corrected). (For interpretation of the references to color
in this ﬁgure legend, the reader is referred to the web version of this
article.)
3.4. Dynamic connectivity: Eﬀect of GABA and glutamate and global Beta-
amyloid on functional connectivity
No signiﬁcant correlations were found between the percentage of
positive weights and GABA or with glutamate (Table 2). Moreover,
global beta-amyloid did not have any signiﬁcant correlations with ei-
genconnectivity weights (Table 3).
3.5. GABA and regional Beta-amyloid relate to dynamic functional
connectivity
To explore interactive eﬀects of GABA and glutamate on beta-
amyloid networks on a multivariate level, CCA was used. By applying
CCA, we explored possible relationships indicated by canonical func-
tions, representing linear combinations of maximal correlation between
Fig. 2. Measuring Regional Gray and White Matter Levels of GABA and Glutamate with Tissue-speciﬁc MRSI at 7 T.
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compared variable sets.
No signiﬁcant interactive eﬀects on the percentage of positive
weights with local beta-amyloid deposition and glutamate were ob-
servable. However, CCA indicated a signiﬁcant diﬀerence in the
amount of time the eigenconnectivities spent in a positive conﬁguration
in subjects with regional beta-amyloid in the Amygdala (F
(2,21)= 3.51, p-FDR=0.048), Frontal lobe (F(2,21)= 3.57, p-
FDR=0.046), Hippocampus (F(2,21)= 3.66, p-FDR=0.04), Insula (F
(2,21)= 3.53, p= 0.048) and Striatum (F(2,21)= 3.74, p-FDR=0.04)
interacting with PCP GABA.
Furthermore, factor cross-loadings derived from CCA indicated that
the ﬁrst network (eigenconnectivity), which captures global-signal
ﬂuctuations, is most strongly altered according to regional beta-amy-
loid and PCP GABA load (r=−0.496) (Fig. 5A). The negative sign
suggested apreference for globally decreased connectivity over time,
related to GABA and beta-amyloid levels. Moreover, strong eﬀect sizes
were found for a fronto-occipital network (r=0.27) (Fig. 5B) and a
temporo-parietal network (r=0.27) (Fig. 4C), which both showed
Fig. 3. Beta-amyloid Load Relates to Changes in Static Functional Connectivity.
Fig. 4. Beta-amyloid Load Interacts with Gray Matter GABA and Glutamate on Static Functional Connectivity Networks.
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preferences for the positive conﬁguration over time, indicating positive
connectivity between involved nodes.
From A-C: Row A illustrates a global network, row B a fronto-
occipital network and row C a temporo-parietal network. From left to
right: Far left is the eigenconnectivity plots wherein the x- and y-axes
represent a regions corresponding to the AAL atlas. Red indicates ‘po-
sitive’ connections and blue indicates ‘negative’ connections. Alongside,
glass brains show the axial, sagittal and coronal views of the 2%
strongest connections in each network. Brain regions are illustrated as
spherical nodes where the size denotes their degree and their color
symbolizes the algebraic sign of the relative node strength (red/yellow
for positive, blue/green for negative). The same color scheme is applied
for the connections. The scatter plots on the far right depict the re-
lationship between the percentage of positive weights (y-axis) and the
ﬁrst canonical of GABA*beta-amyloid (x-axis) with corresponding r-
values to show the strength of this relationship. (For interpretation of
the references to color in this ﬁgure legend, the reader is referred to the
web version of this article.)
Table 2
Correlations between the percentage of positive weights of each eigenconnectivity and GABA and Glutamate measures in the PCP gray matter.
Eigenconnectivity r-value p-FDR Eigenconnectivity r-value p-FDR
GABA 1 0.09 0.74 Glutamate 1 0.21 0.94
2 −0.42 0.41 2 0.17 0.96
3 −0.24 0.5 3 0.03 0.95
4 −0.17 0.73 4 −0.08 0.92
5 0.15 0.68 5 0.04 0.84
6 −0.41 0.25 6 −0.02 0.9
7 0.34 0.36 7 −0.14 1.08
8 0.27 0.45 8 −0.22 1.05
9 0.13 0.67 9 −0.19 0.92
10 −0.002 0.99 10 0.12 1.08
Table 3
Correlations between the percentage of positive weights of each eigen-
connectivity and cortical global beta-amyloid load.
Eigenconnectivity r-value p-FDR
Global ß-amyloid 1 −0.36 0.27
2 −0.42 0.23
3 −0.25 0.4
4 −0.36 0.18
5 −0.12 0.91
6 0.04 0.93
7 0.3 0.28
8 −0.11 0.81
9 0.002 0.99
10 0.07 0.89
Fig. 5. Beta-amyloid Load Interacts with Gray Matter GABA, but not Glutamate, on Dynamic Functional Connectivity Networks.
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4. Discussion
In this cognitively unimpaired old-aged sample, beta-amyloid was
associated with altered PCP connectivity in several clusters, including
the frontal, inferior temporal and occipital regions. These beta-amyloid-
related connectivity changes were moderated by both GABA and glu-
tamate. Though the interaction between beta-amyloid and glutamate
aﬀected PCP connectivity in a diﬀerent cluster array, obtained data
indicate that connectivity changes associated with the interaction be-
tween beta-amyloid and GABA may be more prominent in both static
and dynamic connectivity networks. Interactive static connectivity
changes observed with GABA and beta-amyloid, and also glutamate and
beta-amyloid, showed increases in PCP connectivity primarily in fron-
tomedial regions and decreased PCP connectivity in clusters located
mainly in occipital regions. However, changes to dynamic connectivity
were only found for the interaction of GABA with regional beta-amyloid
deposits in the Amygdala, Frontal Lobe, Hippocampus, Insula and
Striatum, which aﬀected the percentage of positive weights of a global,
a fronto-occipital, and a temporo-parietal network. While GABA and
regional beta-amyloid interactions showed decreased global con-
nectivity, fronto-occipital and temporo-parietal connections indicated a
preference for increased connectivity.
By applying a previously established approach for performing MRSI
in clinical study populations (Schreiner et al., 2018), PCP glutamate
and GABA were assessed speciﬁcally for gray and white matter. This
approach included post-processing, i.e. ROI-deﬁnition and tissue-seg-
mentation, with state-of-the-art acquisition methods that reduce lim-
itations and exploit beneﬁts of the ultra high magnetic ﬁeld strength
achieved at 7 T, including increased signal to noise ratio and high
spatial resolution (Bogner et al., 2012; Fillmer et al., 2015; Henning
et al., 2009; Kirchner et al., 2015). BOLD fMRI resting state data was
investigated using both static and dynamic approaches to provide re-
ﬁned information on intrinsic brain network activity. To this eﬀect
established approaches were used for investigating synchronicity of
BOLD signal in spatially distinct brain regions for static connectivity
(Friston et al., 1993), and also a sliding window approach for assessing
temporal dynamics of brain networks (Chao-Gan and Yu-Feng, 2010;
Preti et al., 2017; Quevenco et al., 2017a; Richiardi et al., 2012).
Our data indicate higher PCP levels of GABA and glutamate in gray
compared to white matter. These ﬁndings are in agreement with earlier
reports for other cortical regions and physiological distribution of
neurotransmitters (Goryawala et al., 2016; Jensen et al., 2005). Our
ﬁnding of GABA and glutamate-related functional connectivity accords
with earlier 3 T single-voxel MR spectroscopy studies (Ghisleni et al.,
2015; Michels et al., 2012; Muthukumaraswamy et al., 2009; Northoﬀ
et al., 2007). Moreover, preclinical studies using two-photon Ca2+
imaging in mice showed that despite a net reduction in cortical neu-
ronal activity, many neurons near beta-amyloid plaques were ‘hyper-
active’ (Busche et al., 2008). Interestingly, the amyloid precursor pro-
tein and its cleavage product beta-amyloid 1–42 have been
demonstrated to interfere with GABAergic transmission (Rice et al.,
2019; Ulrich, 2015). The Clinical evidence on excitatory and inhibitory
neurotransmission in AD is less accurate, as measuring GABA and
glutamate with neuroimaging is technically challenging. Brain gluta-
mate and GABA levels have been demonstrated to be changed in AD
(Bai et al., 2015; Rupsingh et al., 2011) and furthermore linked to al-
tered brain activity in non-demented adults (Ghisleni et al., 2015;
Michels et al., 2012; Muthukumaraswamy et al., 2009).
Also, consistent with earlier reports, we ﬁnd changes in connectivity
associated with beta-amyloid deposits prior to signs of cognitive decline
or other AD-related symptoms (Sheline et al., 2010; Sperling et al.,
2009). Furthermore, a prominent observation in previous literature is
increased connectivity with frontal brain regions, which is thought to
indicate compensatory changes (Agosta et al., 2012; Gould et al., 2006;
Supekar et al., 2008; Wang et al., 2007; Franzmeier et al., 2018; Hahn
et al., 2019). This coincides with our ﬁnding of GABA and glutamate
interacting with global beta-amyloid and PCP connectivity in frontal
regions of the brain. We only found dynamic functional connectivity
changes for the interaction between GABA and beta-amyloid load.
These were speciﬁcally localized to regions intimately linked to the
DMN and aﬀected in early stages of AD (Sperling et al., 2009). Our
ﬁnding of globally decreased connectivity and at the same time selec-
tively increased connectivity between fronto-occipital and temporo-
parietal nodes may appear counterintuitive at ﬁrst glance. However,
local ‘high eﬃciency’ (hyperconnectivity) in brain regions with long
anatomical connections might represent a dynamic strategy to minimise
metabolic costs (Zalesky et al., 2014).
Prior studies have highlighted a relationship between neuronal ex-
citation and beta-amyloid (Cirrito et al., 2008; Cirrito et al., 2005;
Kamenetz et al., 2003; Nitsch et al., 1993; Palop et al., 2007). Thus, we
expected to see major impacts of glutamate on functional connectivity,
when interacting with beta-amyloid, considering its role as a major
excitatory neurotransmitter and its implication in long-term potentia-
tion (LTP). However, while our ﬁndings suggest stronger eﬀects for the
interaction between GABA and beta-amyloid, follow-up studies are
needed to conﬁrm our ﬁndings. Moreover, by better characterizing the
natural history of GABA and beta-amyloid interactions during the
course of AD, promise of the GABAergic system as a target for phar-
macological intervention may be validated (Calvo-Flores Guzman et al.,
2018).
Although this study provides novel ﬁndings and has strengths such
as the unique combination of advanced neuroimaging methods, there
are limitations that need to be taken into consideration. Due to the long
acquisition time of ca. 29min for completing the FIDLOVS MRSI for one
brain region located in the PCP, only a relatively small sized population
of cognitively healthy old aged adults could be investigated. For in-
creased power, subsequent studies might use lower spatial MRSI re-
solution, allowing for a shorter MRSI sequence and larger populations
that include cognitively impaired participants. Also, when using lower
resolution MRSI sequences, follow-up studies might investigate addi-
tional brain regions with high susceptibility to AD pathology, such as
the medio-temporal and parietal cortex. Alternatively, the development
of novel, innovative PET tracers might provide the means for in-
vestigating regional variation of neurotransmitters in AD (Lin et al.,
2017; van der Aart et al., 2018). Moreover, while the ultra-high mag-
netic ﬁeld strength applied in the current study enabled tissue speciﬁc
estimation of GABA (and glutamate), due to the lack of spectral editing
in our MRSI approach, some overlap between spectral peaks of GABA
with other metabolites and macromolecules is to be expected. This
imprecision for estimation of GABA is a limitation of our study, which is
why careful interpretation and replication of our ﬁndings are war-
ranted. Another limitation is the cross-sectional nature of this study. To
fully investigate whether the eﬀects of GABA and glutamate in con-
junction with beta-amyloid deposits on functional connectivity are
more likely pathological in nature or compensatory, it would be ideal to
follow-up with a longitudinal study including individuals that vary in
progression of AD pathology.
In conclusion, this study conﬁrms earlier non-human studies by
providing ﬁrst evidence of a moderating relationship between GABA
and to a lesser degree also glutamate on beta-amyloid related functional
brain networks in cognitively unimpaired old-aged humans. Moreover,
to our knowledge, this study is the ﬁrst attempt to implement non-in-
vasive neuroimaging techniques to assess relationships between GABA,
glutamate and beta-amyloid on functional connectivity. Additional
longitudinal studies are needed to determine how progression of AD
may relate to GABA and glutamate levels, and thus exploit novel pos-
sibilities for neurotransmitter targeted therapeutic intervention.
Declarations of interest
None.
F.C. Quevenco, et al. NeuroImage: Clinical 22 (2019) 101776
8
Acknowledgements
This work was supported by the Swiss National Science Foundation,
Schweizerischer Nationalfonds (33CM30-124111, 320030-125378), the
Clinical Research Priority Program (CRPP) of the University of Zurich
on Molecular Imaging (MINZ) and with the institutional support from
the Institute for Regenerative Medicine (IREM), University of Zurich,
Switzerland, and the Institute for Biomedical Engineering, University of
Zurich and ETH Zurich, Switzerland. This work has been embedded in
organizational structures provided by the Neuroscience Center Zurich
(ZNZ). The authors thank all individuals who shared their time and
volunteered to be a study subject in this project. The authors also thank
Esmeralda Gruber for her assistance in participant recruitment and
Rodolfo Quevenco for proofreading the manuscript.
References
Agosta, F., Pievani, M., Geroldi, C., Copetti, M., Frisoni, G.B., Filippi, M., 2012. Resting
state fMRI in Alzheimer's disease: beyond the default mode network. Neurobiol.
Aging 33, 1564–1578.
Albert, M.S., DeKosky, S.T., Dickson, D., Dubois, B., Feldman, H.H., Fox, N.C., Gamst, A.,
Holtzman, D.M., Jagust, W.J., Petersen, R.C., Snyder, P.J., Carrillo, M.C., Thies, B.,
Phelps, C.H., 2011. The diagnosis of mild cognitive impairment due to Alzheimer's
disease: recommendations from the National Institute on Aging-Alzheimer's
Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers
Dement. 7, 270–279.
Allen, E.A., Damaraju, E., Plis, S.M., Erhardt, E.B., Eichele, T., Calhoun, V.D., 2014.
Tracking whole-brain connectivity dynamics in the resting state. Cereb. Cortex 24,
663–676.
Bai, X., Edden, R.A., Gao, F., Wang, G., Wu, L., Zhao, B., Wang, M., Chan, Q., Chen, W.,
Barker, P.B., 2015. Decreased gamma-aminobutyric acid levels in the parietal region
of patients with Alzheimer's disease. J. Magn. Reson. Imaging 41, 1326–1331.
Benjamini, Y., Hochberg, Y., 1995. Controlling the false discovery rate: a practical and
powerful approach to multiple testing. J. R. Stat. Soc. Ser. B 57, 289–300.
Bero, A.W., Yan, P., Roh, J.H., Cirrito, J.R., Stewart, F.R., Raichle, M.E., Lee, J.M.,
Holtzman, D.M., 2011. Neuronal activity regulates the regional vulnerability to
amyloid-beta deposition. Nat. Neurosci. 14, 750–756.
Bogner, W., Gruber, S., Trattnig, S., Chmelik, M., 2012. High-resolution mapping of
human brain metabolites by free induction decay (1)H MRSI at 7 T. NMR Biomed. 25,
873–882.
Brettschneider, J., Del Tredici, K., Lee, V.M., Trojanowski, J.Q., 2015. Spreading of pa-
thology in neurodegenerative diseases: a focus on human studies. Nat. Rev. Neurosci.
16, 109–120.
Buckner, R.L., Andrews-Hanna, J.R., Schacter, D.L., 2008. The brain's default network:
anatomy, function, and relevance to disease. Ann. N. Y. Acad. Sci. 1124, 1–38.
Buckner, R.L., Sepulcre, J., Talukdar, T., Krienen, F.M., Liu, H., Hedden, T., Andrews-
Hanna, J.R., Sperling, R.A., Johnson, K.A., 2009. Cortical hubs revealed by intrinsic
functional connectivity: mapping, assessment of stability, and relation to Alzheimer's
disease. J. Neurosci. 29, 1860–1873.
Busche, M.A., Eichhoﬀ, G., Adelsberger, H., Abramowski, D., Wiederhold, K.H., Haass, C.,
Staufenbiel, M., Konnerth, A., Garaschuk, O., 2008. Clusters of hyperactive neurons
near amyloid plaques in a mouse model of Alzheimer's disease. Science 321,
1686–1689.
Calvo-Flores Guzman, B., Vinnakota, C., Govindpani, K., Waldvogel, H.J., Faull, R.L.M.,
Kwakowsky, A., 2018. The GABAergic system as a therapeutic target for Alzheimer's
disease. J. Neurochem. 146, 649–669.
Chang, C., Glover, G.H., 2010. Time-frequency dynamics of resting-state brain con-
nectivity measured with fMRI. Neuroimage 50, 81–98.
Chao-Gan, Y., Yu-Feng, Z., 2010. DPARSF: a MATLAB toolbox for "Pipeline" data analysis
of resting-state fMRI. Front. Syst. Neurosci. 4, 13.
Cieri, F., Esposito, R., 2018. Neuroaging through the Lens of the resting state networks.
Biomed. Res. Int. 2018, 5080981.
Cirrito, J.R., Yamada, K.A., Finn, M.B., Sloviter, R.S., Bales, K.R., May, P.C., Schoepp,
D.D., Paul, S.M., Mennerick, S., Holtzman, D.M., 2005. Synaptic activity regulates
interstitial ﬂuid amyloid-beta levels in vivo. Neuron 48, 913–922.
Cirrito, J.R., Kang, J.E., Lee, J., Stewart, F.R., Verges, D.K., Silverio, L.M., Bu, G.,
Mennerick, S., Holtzman, D.M., 2008. Endocytosis is required for synaptic activity-
dependent release of amyloid-beta in vivo. Neuron 58, 42–51.
Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small,
G.W., Roses, A.D., Haines, J.L., Pericak-Vance, M.A., 1993. Gene dose of apolipo-
protein E type 4 allele and the risk of Alzheimer's disease in late onset families.
Science 261, 921–923.
Dubois, B., Hampel, H., Feldman, H.H., Scheltens, P., Aisen, P., Andrieu, S., Bakardjian,
H., Benali, H., Bertram, L., Blennow, K., Broich, K., Cavedo, E., Crutch, S., Dartigues,
J.F., Duyckaerts, C., Epelbaum, S., Frisoni, G.B., Gauthier, S., Genthon, R., Gouw,
A.A., Habert, M.O., Holtzman, D.M., Kivipelto, M., Lista, S., Molinuevo, J.L.,
O'Bryant, S.E., Rabinovici, G.D., Rowe, C., Salloway, S., Schneider, L.S., Sperling, R.,
Teichmann, M., Carrillo, M.C., Cummings, J., Jack, C.R., Proceedings of the Meeting
of the International Working, G., the American Alzheimer's Association on "The
Preclinical State of, A.D., July, Washington Dc, U.S.A, 2016. Preclinical Alzheimer's
disease: deﬁnition, natural history, and diagnostic criteria. Alzheimers Dement. 12,
292–323.
Esposito, R., Mosca, A., Pieramico, V., Cieri, F., Cera, N., Sensi, S.L., 2013.
Characterization of resting state activity in MCI individuals. PeerJ 1, e135.
Ferreira, L.K., Busatto, G.F., 2013. Resting-state functional connectivity in normal brain
aging. Neurosci. Biobehav. Rev. 37, 384–400.
Fillmer, A., Kirchner, T., Cameron, D., Henning, A., 2015. Constrained image-based B0
shimming accounting for "local minimum traps" in the optimization and ﬁeld in-
homogeneities outside the region of interest. Magn. Reson. Med. 73, 1370–1380.
Folstein, M.F., Folstein, S.E., McHugh, P.R., 1975. Mini-mental state: A practical method
for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12,
189–198.
Fox, M.D., Raichle, M.E., 2007. Spontaneous ﬂuctuations in brain activity observed with
functional magnetic resonance imaging. Nat. Rev. Neurosci. 8, 700–711.
Franzmeier, N., Duering, M., Weiner, M., Dichgans, M., Ewers, M., Alzheimer's Disease
Neuroimaging, I., 2017. Left frontal cortex connectivity underlies cognitive reserve in
prodromal Alzheimer disease. Neurology 88, 1054–1061.
Franzmeier, N., Hartmann, J., Taylor, A.N.W., Araque-Caballero, M.A., Simon-Vermot, L.,
Kambeitz-Ilankovic, L., Burger, K., Catak, C., Janowitz, D., Muller, C., Ertl-Wagner,
B., Stahl, R., Dichgans, M., Duering, M., Ewers, M., 2018. The left frontal cortex
supports reserve in aging by enhancing functional network eﬃciency. Alzheimers
Res. Ther. 10, 28.
Friston, K.J., Frith, C.D., Liddle, P.F., Frackowiak, R.S., 1993. Functional connectivity: the
principal-component analysis of large (PET) data sets. J. Cereb. Blood Flow Metab.
13, 5–14.
Ghisleni, C., Bollmann, S., Poil, S.S., Brandeis, D., Martin, E., Michels, L., O'Gorman, R.L.,
Klaver, P., 2015. Subcortical glutamate mediates the reduction of short-range func-
tional connectivity with age in a developmental cohort. J. Neurosci. 35, 8433–8441.
Gietl, A.F., Warnock, G., Riese, F., Kalin, A.M., Saake, A., Gruber, E., Leh, S.E., Unschuld,
P.G., Kuhn, F.P., Burger, C., Mu, L., Seifert, B., Nitsch, R.M., Schibli, R., Ametamey,
S.M., Buck, A., Hock, C., 2015. Regional cerebral blood ﬂow estimated by early PiB
uptake is reduced in mild cognitive impairment and associated with age in an
amyloid-dependent manner. Neurobiol. Aging 36, 1619–1628.
Goryawala, M.Z., Sheriﬀ, S., Maudsley, A.A., 2016. Regional distributions of brain glu-
tamate and glutamine in normal subjects. NMR Biomed. 29, 1108–1116.
Gould, R.L., Arroyo, B., Brown, R.G., Owen, A.M., Bullmore, E.T., Howard, R.J., 2006.
Brain mechanisms of successful compensation during learning in Alzheimer disease.
Neurology 67, 1011–1017.
Gousias, I.S., Rueckert, D., Heckemann, R.A., Dyet, L.E., Boardman, J.P., Edwards, A.D.,
Hammers, A., 2008. Automatic segmentation of brain MRIs of 2-year-olds into 83
regions of interest. Neuroimage 40, 672–684.
Gregoire, J., Van der Linden, M., 1997. Eﬀect of age on forward and backward digit spans.
Aging Neuropsychol. Cognit. 4, 140–149.
Greicius, M.D.K., Reiss, A.L., Menon, V., 2003. Functional connectivity in the resting
brain: a network analysis of the default mode hypothesis. PNAS 100, 253–258.
Hahn, A., Strandberg, T.O., Stomrud, E., Nilsson, M., van Westen, D., Palmqvist, S.,
Ossenkoppele, R., Hansson, O., 2019. Association Between Earliest Amyloid Uptake
and Functional Connectivity in Cognitively Unimpaired Elderly. Cereb. Cortex.
Hammers, A., Allom, R., Koepp, M.J., Free, S.L., Myers, R., Lemieux, L., Mitchell, T.N.,
Brooks, D.J., Duncan, J.S., 2003. Three-dimensional maximum probability atlas of
the human brain, with particular reference to the temporal lobe. Hum. Brain Mapp.
19, 224–247.
Handwerker, D.A., Roopchansingh, V., Gonzalez-Castillo, J., Bandettini, P.A., 2012.
Periodic changes in fMRI connectivity. Neuroimage 63, 1712–1719.
Hedden, T., Van Dijk, K.R., Becker, J.A., Mehta, A., Sperling, R.A., Johnson, K.A.,
Buckner, R.L., 2009. Disruption of functional connectivity in clinically normal older
adults harboring amyloid burden. J. Neurosci. 29, 12686–12694.
Henning, A., Fuchs, A., Murdoch, J.B., Boesiger, P., 2009. Slice-selective FID acquisition,
localized by outer volume suppression (FIDLOVS) for (1)H-MRSI of the human brain
at 7 T with minimal signal loss. NMR Biomed. 22, 683–696.
Hutchison, R.M., Womelsdorf, T., Allen, E.A., Bandettini, P.A., Calhoun, V.D., Corbetta,
M., Della Penna, S., Duyn, J.H., Glover, G.H., Gonzalez-Castillo, J., Handwerker,
D.A., Keilholz, S., Kiviniemi, V., Leopold, D.A., de Pasquale, F., Sporns, O., Walter,
M., Chang, C., 2013. Dynamic functional connectivity: promise, issues, and inter-
pretations. Neuroimage 80, 360–378.
Jack Jr., C.R., Lowe, V.J., Weigand, S.D., Wiste, H.J., Senjem, M.L., Knopman, D.S.,
Shiung, M.M., Gunter, J.L., Boeve, B.F., Kemp, B.J., Weiner, M., Petersen, R.C.,
Alzheimer's Disease Neuroimaging, I, 2009. Serial PIB and MRI in normal, mild
cognitive impairment and Alzheimer's disease: implications for sequence of patho-
logical events in Alzheimer's disease. Brain 132, 1355–1365.
Jagust, W.J., Mormino, E.C., 2011. Lifespan brain activity, beta-amyloid, and Alzheimer's
disease. Trends Cogn. Sci. 15, 520–526.
Jensen, J.E., Frederick Bde, B., Renshaw, P.F., 2005. Grey and white matter GABA level
diﬀerences in the human brain using two-dimensional, J-resolved spectroscopic
imaging. NMR Biomed. 18, 570–576.
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S.,
Manilow, R., 2003. APP processing and synaptic function. Neuron 37, 925–937.
Kantarci, K., Lowe, V., Przybelski, S.A., Weigand, S.D., Senjem, M.L., Ivnik, R.J.,
Preboske, G.M., Roberts, R., Geda, Y.E., Boeve, B.F., Knopman, D.S., Petersen, R.C.,
Jack Jr., C.R., 2012. APOE modiﬁes the association between Abeta load and cognition
in cognitively normal older adults. Neurology 78, 232–240.
Kirchner, T., Fillmer, A., Tsao, J., Pruessmann, K.P., Henning, A., 2015. Reduction of
voxel bleeding in highly accelerated parallel (1) H MRSI by direct control of the
spatial response function. Magn. Reson. Med. 73, 469–480.
Klunk, W.E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D.P., Bergstrom, M.,
Savitcheva, I., Huang, G.F., Estrada, S., Ausen, B., Debnath, M.L., Barletta, J., Price,
F.C. Quevenco, et al. NeuroImage: Clinical 22 (2019) 101776
9
J.C., Sandell, J., Lopresti, B.J., Wall, A., Koivisto, P., Antoni, G., Mathis, C.A.,
Langstrom, B., 2004. Imaging brain amyloid in Alzheimer's disease with Pittsburgh
Compound-B. Ann. Neurol. 55, 306–319.
Kreis, R., 2016. The trouble with quality ﬁltering based on relative Cramer-Rao lower
bounds. Magn. Reson. Med. 75, 15–18.
Lange, K.L., Bondi, M.W., Salmon, D.P., Galasko, D., Delis, D.C., Thomas, R.G., Thal, L.J.,
2002. Decline in verbal memory during preclinical Alzheimer's disease: examination
of the eﬀect of APOE genotype. J. Int. Neuropsychol. Soc. 8, 943–955.
Leonardi, N., Richiardi, J., Gschwind, M., Simioni, S., Annoni, J.M., Schluep, M.,
Vuilleumier, P., Van De Ville, D., 2013. Principal components of functional con-
nectivity: a new approach to study dynamic brain connectivity during rest.
Neuroimage 83, 937–950.
Lin, S.F., Bois, F., Holden, D., Nabulsi, N., Pracitto, R., Gao, H., Kapinos, M., Teng, J.K.,
Shirali, A., Ropchan, J., Carson, R.E., Elmore, C.S., Vasdev, N., Huang, Y., 2017. The
search for a subtype-selective PET imaging agent for the GABAA receptor complex:
evaluation of the radiotracer [(11)C]ADO in nonhuman primates. Mol. Imaging 16,
1536012117731258.
Lustig, C., Snyder, A.Z., Bhakta, M., O'Brien, K.C., McAvoy, M., Raichle, M.E., Morris, J.C.,
Buckner, R.L., 2003. Functional deactivations: change with age and dementia of the
Alzheimer type. Proc. Natl. Acad. Sci. U. S. A. 100, 14504–14509.
Michels, L., Martin, E., Klaver, P., Edden, R., Zelaya, F., Lythgoe, D.J., Luchinger, R.,
Brandeis, D., O'Gorman, R.L., 2012. Frontal GABA levels change during working
memory. PLoS One 7, e31933.
Mormino, E.C., Smiljic, A., Hayenga, A.O., Onami, S.H., Greicius, M.D., Rabinovici, G.D.,
Janabi, M., Baker, S.L., Yen, I.V., Madison, C.M., Miller, B.L., Jagust, W.J., 2011.
Relationships between beta-amyloid and functional connectivity in diﬀerent com-
ponents of the default mode network in aging. Cereb. Cortex 21, 2399–2407.
Muthukumaraswamy, S.D.E., E, R.A., Jones, D.K., Swettenham, J.B., Singh, K.D., 2009.
Resting GABA concentration predicts peak gamma frequency and fMRI amplitude in
response to visual stimulation in humans. PNAS 106, 8356–8361.
Nicholas, L.E., Brookshire, R.H., Schumacher, J.G., Porrazzo, S.A., 1988. The Boston
naming test: revised administration and scoring procedures and normative informa-
tion for non-brain-damaged adults. Clin. Aphasiol. 18, 103–115.
Nitsch, R.M., Farber, S.A., Growden, J.H., Wurtman, R.J., 1993. Release of amyloid ß-
protein precursor derivatives by electrical depolarization of rat hipocampal slices.
Proc. Natl. Acad. Sci. U. S. A. 90, 5191–5193.
Northoﬀ, G., Walter, M., Schulte, R.F., Beck, J., Dydak, U., Henning, A., Boeker, H.,
Grimm, S., Boesiger, P., 2007. GABA concentrations in the human anterior cingulate
cortex predict negative BOLD responses in fMRI. Nat. Neurosci. 10, 1515–1517.
Palop, J.J., Chin, J., Roberson, E.D., Wang, J., Thwin, M.T., Bien-Ly, N., Yoo, J., Ho, K.O.,
Yu, G.Q., Kreitzer, A., Finkbeiner, S., Noebels, J.L., Mucke, L., 2007. Aberrant ex-
citatory neuronal activity and compensatory remodeling of inhibitory hippocampal
circuits in mouse models of Alzheimer's disease. Neuron 55, 697–711.
Preti, M.G., Bolton, T.A., Van De Ville, D., 2017. The dynamic functional connectome:
state-of-the-art and perspectives. Neuroimage. 160, 41–54.
Provencher, S.W., 2001. Automatic quantitation of localized in vivo 1H spectra with
LCModel. NMR Biomed. 14, 260–264.
Quevenco, F.C.P., van Bergen, J.M.G., Hua, J., Wyss, M., Xu, Li, Schreiner, S.J.,
Steininger, S.C., Meyer, R., Meier, I.B., Brickman, A.M., Leh, S.E., Gietl, A.F., Buck,
A., Nitsch, R.M., Pruessman, K.P., van Zijl, P.C.M., Hock, C., Van De Ville, D.,
Unschuld, P.G., 2017a. Memory performance-related dynamic brain connectivity
indicates pathological burden and genetic risk for Alzheimer's disease. Alzheimers
Res. Ther. 9.
Quevenco, F.C., Preti, M.G., van Bergen, J.M., Hua, J., Wyss, M., Li, X., Schreiner, S.J.,
Steininger, S.C., Meyer, R., Meier, I.B., Brickman, A.M., Leh, S.E., Gietl, A.F., Buck,
A., Nitsch, R.M., Pruessmann, K.P., van Zijl, P.C., Hock, C., Van De Ville, D.,
Unschuld, P.G., 2017b. Memory performance-related dynamic brain connectivity
indicates pathological burden and genetic risk for Alzheimer's disease. Alzheimers
Res. Ther. 9, 24.
Raichle, M.E.M., M, A., Snyder, A.Z., Powers, W.J., Gusnard, D.A., Shulman, G.L., 2001. A
default mode of brain function. PNAS 98, 676–682.
Rice, H.C., de Malmazet, D., Schreurs, A., Frere, S., Van Molle, I., Volkov, A.N., Creemers,
E., Vertkin, I., Nys, J., Ranaivoson, F.M., Comoletti, D., Savas, J.N., Remaut, H.,
Balschun, D., Wierda, K.D., Slutsky, I., Farrow, K., De Strooper, B., de Wit, J., 2019.
Secreted amyloid-beta precursor protein functions as a GABABR1a ligand to mod-
ulate synaptic transmission. Science 363.
Richiardi, J., Gschwind, M., Simioni, S., Annoni, J.M., Greco, B., Hagmann, P., Schluep,
M., Vuilleumier, P., Van De Ville, D., 2012. Classifying minimally disabled multiple
sclerosis patients from resting state functional connectivity. Neuroimage 62,
2021–2033.
Robinson, J.L., Lee, E.B., Xie, S.X., Rennert, L., Suh, E., Bredenberg, C., Caswell, C., Van
Deerlin, V.M., Yan, N., Yousef, A., Hurtig, H.I., Siderowf, A., Grossman, M., McMillan,
C.T., Miller, B., Duda, J.E., Irwin, D.J., Wolk, D., Elman, L., McCluskey, L., Chen-
Plotkin, A., Weintraub, D., Arnold, S.E., Brettschneider, J., Lee, V.M., Trojanowski,
J.Q., 2018. Neurodegenerative disease concomitant proteinopathies are prevalent,
age-related and APOE4-associated. Brain 141, 2181–2193.
Rupsingh, R., Borrie, M., Smith, M., Wells, J.L., Bartha, R., 2011. Reduced hippocampal
glutamate in Alzheimer disease. Neurobiol. Aging 32, 802–810.
Schreiner, S.J., Liu, X., Gietl, A.F., Wyss, M., Steininger, S.C., Gruber, E., Treyer, V.,
Meier, I.B., Kalin, A.M., Leh, S.E., Buck, A., Nitsch, R.M., Pruessmann, K.P., Hock, C.,
Unschuld, P.G., 2014. Regional Fluid-Attenuated Inversion Recovery (FLAIR) at 7
Tesla correlates with amyloid beta in hippocampus and brainstem of cognitively
normal elderly subjects. Front. Aging Neurosci. 6, 240.
Schreiner, S.J., Kirchner, T., Wyss, M., Van Bergen, J.M., Quevenco, F.C., Steininger, S.C.,
Griﬃth, E.Y., Meier, I., Michels, L., Gietl, A.F., Leh, S.E., Brickman, A.M., Hock, C.,
Nitsch, R.M., Pruessmann, K.P., Henning, A., Unschuld, P.G., 2016. Low episodic
memory performance in cognitively normal elderly subjects is associated with in-
creased posterior cingulate gray matter N-acetylaspartate: a 1H MRSI study at 7
Tesla. Neurobiol. Aging 48, 195–203.
Schreiner, S.J., Kirchner, T., Narkhede, A., Wyss, M., Van Bergen, J.M.G., Steininger, S.C.,
Gietl, A., Leh, S.E., Treyer, V., Buck, A., Pruessmann, K.P., Nitsch, R.M., Hock, C.,
Henning, A., Brickman, A.M., Unschuld, P.G., 2018. Brain amyloid burden and cer-
ebrovascular disease are synergistically associated with neurometabolism in cogni-
tively unimpaired older adults. Neurobiol. Aging 63, 152–161.
Seeley, W.W., 2017. Mapping neurodegenerative Disease onset and progression. Cold
Spring Harb. Perspect. Biol. 9.
Sepulcre, J., Sabuncu, M.R., Li, Q., El Fakhri, G., Sperling, R., Johnson, K.A., 2017. Tau
and amyloid-beta proteins distinctively associate to functional network changes in
the aging brain. Alzheimers Dement. 13, 1261–1269.
Sheline, Y.I., Raichle, M.E., Snyder, A.Z., Morris, J.C., Head, D., Wang, S., Mintun, M.A.,
2010. Amyloid plaques disrupt resting state default mode network connectivity in
cognitively normal elderly. Biol. Psychiatry 67, 584–587.
Sorg, C., Riedl, V., Muhlau, M., Calhoun, V.D., Eichele, T., Laer, L., Drzezga, A., Forstl, H.,
Kurz, A., Zimmer, C., Wohlschlager, A.M., 2007. Selective changes of resting-state
networks in individuals at risk for Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A.
104, 18760–18765.
Sperling, R.A., Laviolette, P.S., O'Keefe, K., O'Brien, J., Rentz, D.M., Pihlajamaki, M.,
Marshall, G., Hyman, B.T., Selkoe, D.J., Hedden, T., Buckner, R.L., Becker, J.A.,
Johnson, K.A., 2009. Amyloid deposition is associated with impaired default network
function in older persons without dementia. Neuron 63, 178–188.
Sperling, R.A., Aisen, P.S., Beckett, L.A., Bennett, D.A., Craft, S., Fagan, A.M., Iwatsubo,
T., Jack Jr., C.R., Kaye, J., Montine, T.J., Park, D.C., Reiman, E.M., Rowe, C.C.,
Siemers, E., Stern, Y., Yaﬀe, K., Carrillo, M.C., Thies, B., Morrison-Bogorad, M.,
Wagster, M.V., Phelps, C.H., 2011. Toward deﬁning the preclinical stages of
Alzheimer's disease: recommendations from the National Institute on Aging-
Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Alzheimers Dement. 7, 280–292.
Steininger, S.C., Liu, X., Gietl, A., Wyss, M., Schreiner, S., Gruber, E., Treyer, V., Kalin, A.,
Leh, S., Buck, A., Nitsch, R.M., Prussmann, K.P., Hock, C., Unschuld, P.G., 2014.
Cortical amyloid Beta in cognitively Normal elderly adults is associated with de-
creased network eﬃciency within the Cerebro-cerebellar system. Front. Aging
Neurosci. 6, 52.
Supekar, K., Menon, V., Rubin, D., Musen, M., Greicius, M.D., 2008. Network analysis of
intrinsic functional brain connectivity in Alzheimer's disease. PLoS Comput. Biol. 4,
e1000100.
Teipel, S., Grothe, M.J., Alzheimer s Disease Neuroimaging, I, 2016a. Does posterior
cingulate hypometabolism result from disconnection or local pathology across pre-
clinical and clinical stages of Alzheimer's disease? Eur. J. Nucl. Med. Mol. Imaging 43,
526–536.
Teipel, S.J., Grothe, M.J., Metzger, C.D., Grimmer, T., Sorg, C., Ewers, M., Franzmeier, N.,
Meisenzahl, E., Kloppel, S., Borchardt, V., Walter, M., Dyrba, M., 2016b. Robust
detection of impaired resting state functional connectivity networks in Alzheimer's
Disease using elastic net regularized regression. Front. Aging Neurosci. 8, 318.
Tkac, I., Starcuk, Z., Choi, I.Y., Gruetter, R., 1999. In vivo 1H NMR spectroscopy of rat
brain at 1 ms echo time. Magn. Reson. Med. 41, 649–656.
Tombaugh, T., 2004. Trail making test A and B: normative data stratiﬁed by age and
education. Arch. Clin. Neuropsychol. 19, 203–214.
Ulrich, D., 2015. Amyloid-beta impairs synaptic inhibition via GABA(A) receptor en-
docytosis. J. Neurosci. 35, 9205–9210.
van den Heuvel, M.P., Mandl, R.C., Kahn, R.S., Hulshoﬀ Pol, H.E., 2009. Functionally
linked resting-state networks reﬂect the underlying structural connectivity archi-
tecture of the human brain. Hum. Brain Mapp. 30, 3127–3141.
van der Aart, J., Golla, S.S.V., van der Pluijm, M., Schwarte, L.A., Schuit, R.C., Klein, P.J.,
Metaxas, A., Windhorst, A.D., Boellaard, R., Lammertsma, A.A., van Berckel, B.N.M.,
2018. First in human evaluation of [(18)F]PK-209, a PET ligand for the ion channel
binding site of NMDA receptors. EJNMMI Res. 8, 69.
Wang, K., Liang, M., Wang, L., Tian, L., Zhang, X., Li, K., Jiang, T., 2007. Altered func-
tional connectivity in early Alzheimer's disease: a resting-state fMRI study. Hum.
Brain Mapp. 28, 967–978.
Whitﬁeld-Gabrieli, S., Nieto-Castanon, A., 2012. Conn: a functional connectivity toolbox
for correlated and anticorrelated brain networks. Brain Connect 2, 125–141.
Zalesky, A., Fornito, A., Cocchi, L., Gollo, L.L., Breakspear, M., 2014. Time-resolved
resting-state brain networks. Proc. Natl. Acad. Sci. U. S. A. 111, 10341–10346.
F.C. Quevenco, et al. NeuroImage: Clinical 22 (2019) 101776
10
